Alterations in Saliva Steroid Hormone Levels After Oral Mifepristone Administration in Women With Pregnancies of Greater Than 41 Weeks' Gestation

Abstract

The objective of this study is to describe the effects of oral mifepristone administration on saliva levels of estradiol, estriol, progesterone, and cortisol in women with postdates pregnancy. As an adjunct to a randomized controlled trial comparing 200 mg oral mifepristone to placebo for cervical ripening and labor induction in women with pregnancies greater than 41 weeks' gestation, saliva samples were obtained before drug administration and every 6 hours thereafter for 24 hours. Estradiol, estriol, progesterone, and cortisol levels were measured by radioimmunoassay. Ninety-seven participants received mifepristone, and 83 received placebo. Saliva steroid hormone data were available for 71 mifepristone-and 60 placebo-treated women. Mean baseline saliva estradiol, estriol, progesterone, and cortisol levels were similar between study groups. At 24 hours after study medication administration, saliva estradiol, estriol, progesterone, and cortisol levels in the mifepristone group were significantly elevated compared with baseline. There was no significant change in hormone levels in the placebo group. Oral mifepristone significantly increased saliva estradiol, estriol, progesterone, and cortisol compared with placebo. This may reflect mifepristone's antiglucocorticoid properties. These hormone elevations may contribute to the mechanism by which mifepristone causes cervical ripening and increases myometrial activity.

Keywords

Mifepristone saliva steroids labor induction.

Get full access to this article

View all access options for this article.

References

Cabrol MD , Dubois MD , Cronje H. , et al. Induction of labor with mifepristone (RU486) in intrauterine fetal death. Am J Obstet Gynecol. 1990;163:540-542.

Frydman R. , Lelaidier C. , Baton-Saint-Mleux C. , et al. Labor induction in women at term with mifepristone (RU486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol. 1992;80:972-975.

Stenlund PM , Edman G. , Aedo AR , et al. Induction of labor with mifepristone-a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand. 1999;78:793-798.

Elliott CL , Brennand JE , Calder AA The effects of mifepristone of cervical ripening and labor induction in primigravidae . Obstet Gynecol. 1998;92:804-809.

Giacalone PL , Daures JP , Faure JM , et al.The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns . Eur J Obstet Gynecol Reprod Biol. 2001;97: 30-34.

Vining RF , McGinley, Symons RG. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin Chem. 1983;29:1752-1756.

Lachelin GCL , McGarrigle HHG. A comparison of saliva, plasma unconjugated and plasma total oestriol levels throughout normal pregnancy . Br J Obstet Gynecol. 1984;91:1203-1209.

Wing DA , Fassett MJ , Mishell DR Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial. Obstet Gynecol. 2000;96:543-548.

Darne J. , McGarrigle HHG , Lachelin GCL. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol:progesterone ratio. Br J Obstet Gynaecol. 1987;94:227-235.

10.

Scott EM , McGarrigle HHG , Lachelin GCL. The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroids binding globulin levels. J Clin Endocrinol Metab. 1990;71:639-644.

11.

Heikinheimo O. Clinical pharmacokinetics of mifepristone . Clin Pharmacokinet. 1997;33:7-17.

12.

Heikinihemo O. , Kekkonen R. , Lahteenmaki P. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. Contraception. 2003 ;68:421-426.

13.

Stjernholm YM , Sahlin L. , Eriksson HA , et al. Cervical ripening after treatment with prostaglandin E2 or antiprogestin (RU486): possible mechanisms in relation to gonadal steroids. Eur J Obstet Gynecol Reprod Biol. 1999;84:83-88.

14.

Weng L. , Jiao L. , Tang X. Histological study of the uterine cervix during termination of early pregnancy by mifepristone and prostaglandins. Chinese J Obstet Gynecol . 1995;30:522-525.

15.

Di WL , Lachelin GC , McGarrigle HH , et al. Oestriol and oestradiol increase cell to cell communication and connexin43 protein expression in human myometrium. Mol Hum Reprod. 2001;7:671-679.

16.

Dong YL , Yallampalli C. Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP2 and contractile FP receptors in the rat uterus. Biol Reprod . 2000;62: 533-539.

17.

Giacalone PL , Targosz V. , Laffargue F. , et al. Cervical ripening with mifepristone before labor induction: a randomized study. Obstet Gynecol . 1998;92:487-492.

18.

Hill NC , Selinger M. , Ferguson J. , et al. The placental transfer of mifepristone (RU486) during the second trimester and its influence upon maternal and fetal steroid concentrations . Br J Obstet Gynaecol. 1990;97:406-411.

19.

Norman JE , Kelly RW , Baird DT Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivo. Hum Rep. 1991;6(5):740-744.

20.

Karalis K. , Goodwin G. , Mazjoub JA Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med. 1996;2:556-560.

21.

Darne J. , McGarrigle HHG , Lachelin GCL. Increased saliva oestriol to progesterone ratio before idiopathic preterm delivery: a possible predictor for preterm labour? BMJ. 1987;294:270-272.

22.

Moran DJ , McGarrigle HHG , Lachelin GCL. Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation. Am J Obstet Gynecol . 1992;167:1563-1564.